Table 4.
Median of cf-PWV for subjects with T2D grouped according to the urinary levels of IL-18.
| UIL-18 (pg/mg UCr) | |||
|---|---|---|---|
| ≤ 140.82 | > 140.82 | p | |
| cf-PWV (m/s) 95%CI | 8.050 (7.634, 8.466) | 9.046 (8.629, 9.462) | 0.001 |
| cf-PWV (m/s) 95%CI a | 8.142 (7.719, 8.565) | 8.914 (8.561, 9.311) | 0.009 |
| cf-PWV (m/s) 95%CI b | 8.475 (8.036, 8.915) | 9.064 (8.679, 9.449) | 0.046 |
cf-PWV, carotid–femoral pulse wave velocity; UCr, urinary creatinine; UIL-18, urinary interleukin-18.
a, Controlling for age and gender.
b, Additionally controlling for traditional arterial stiffness risk factors (BMI, duration of T2D, hypertension, Hb, albumin, TC, and HDL), and the presence of DKD (UACR ≥ 30 mg/g and/or eGFR < 60 ml/min/1.73 m2).